PRC2 loss drives MPNST metastasis and matrix remodelingQierra R. Brockman(University of Colorado Cancer Center), Rebecca D. Dodd(University of Iowa)JCI InsightSeptember 6, 202210.1172/jci.insight.157502Cited by 21SaveCiteExport RISWatch citationsRelated PapersAugmenting chemotherapy with low-dose decitabine through an immune-independent mechanism|JCI Insight|2022|9